$10.3B
$13.1 Million
0.18% of portfolio
237,851
Q1 2025
Reduced 21.72%
$18B
$12.9 Million
0.18% of portfolio
37,085
Q2 2025
Reduced 1.1%
$42.2B
$13.1 Million
0.18% of portfolio
42,022
Q2 2025
Reduced 17.31%
$5.6B
$12.3 Million
0.17% of portfolio
80,000
Q4 2020
New
$5.88B
$11.9 Million
0.16% of portfolio
175,250
Q2 2025
Reduced 1.1%
$3.62B
$11.8 Million
0.16% of portfolio
85,809
Q1 2025
Reduced 18.9%
$71.3B
$11.5 Million
0.16% of portfolio
621,580
Q2 2025
Reduced 28.58%
$12.8B
$11.7 Million
0.16% of portfolio
50,636
Q2 2025
Added 15.49%
$46.2B
$12 Million
0.16% of portfolio
75,104
Q2 2025
Reduced 1.1%
$1.33B
$11.1 Million
0.15% of portfolio
621,784
Q4 2024
Added 19.17%
$18.1B
$11.3 Million
0.15% of portfolio
128,723
Q2 2025
Reduced 3.14%
$9.13B
$8.29 Million
0.11% of portfolio
126,452
Q2 2025
Reduced 1.01%
$1.54B
$8.39 Million
0.11% of portfolio
490,329
Q2 2025
Added 95.87%
$24.1B
$7.64 Million
0.1% of portfolio
95,468
Q2 2025
Reduced 2.49%
$4.57B
$7.15 Million
0.1% of portfolio
250,000
Q4 2024
New
$6.11B
$6.87 Million
0.09% of portfolio
58,000
Q3 2020
Added 9.43%
$139B
$6.96 Million
0.09% of portfolio
9,068
Q2 2025
Added 34.14%
$1.94B
$6.34 Million
0.09% of portfolio
195,000
Q2 2025
Added 105.26%
$7.69B
$4.1 Million
0.06% of portfolio
129,265
Q2 2025
Reduced 1.22%
$55.1B
$3.88 Million
0.05% of portfolio
6,841
Q2 2025
Added 19.89%
$3.43B
$3.74 Million
0.05% of portfolio
398,069
Q4 2024
Added 10.02%
-
$2.82 Million
0.04% of portfolio
-
Q2 2025
Added 96.32%
-
$2.7 Million
0.04% of portfolio
-
Q2 2025
New
$101B
$2.59 Million
0.04% of portfolio
3,536
Q4 2024
Reduced 18.37%
$4.42B
$2.36 Million
0.03% of portfolio
99,506
Q2 2025
New
$20.2B
$2.46 Million
0.03% of portfolio
23,491
Q2 2025
Added 32.78%
$38.4B
$2.36 Million
0.03% of portfolio
7,881
Q2 2025
Added 41.52%
$159B
$2.44 Million
0.03% of portfolio
8,148
Q2 2025
Added 35.87%
$10.5B
$2.03 Million
0.03% of portfolio
22,278
Q4 2024
Reduced 18.69%
$47.3B
$1.91 Million
0.03% of portfolio
21,313
Q1 2025
New
$79.5B
$1.98 Million
0.03% of portfolio
11,494
Q2 2025
Reduced 99.34%
$26.4B
$2.39 Million
0.03% of portfolio
21,518
Q2 2025
New
$374M
$2.17 Million
0.03% of portfolio
1,260,000
Q2 2024
Added 18.87%
$62.8B
$2.1 Million
0.03% of portfolio
6,549
Q4 2024
Added 14.15%
$8.02B
$2.46 Million
0.03% of portfolio
55,967
Q2 2025
Added 25.24%
-
$1.28 Million
0.02% of portfolio
-
Q1 2025
New
$0
$1.58 Million
0.02% of portfolio
39,569
Q2 2025
New
$105M
$1.41 Million
0.02% of portfolio
1,928,464
Q2 2023
Added 107.7%
Karyopharm Therapeutics Inc
-
$431,000
0.01% of portfolio
-
Q1 2025
New
$123B
$1.05 Million
0.01% of portfolio
3,394
Q4 2024
Reduced 18.65%
$55.1B
$487,000
0.01% of portfolio
35,472
Q2 2025
Reduced 32.89%
$11.1B
$479,000
0.01% of portfolio
8,421
Q2 2025
Reduced 0.01%
$51.7B
$563,000
0.01% of portfolio
4,409
Q1 2025
Reduced 67.03%